SABCS: Genetic Test May Help Predict DCIS Recurrence

December 12, 2014 6:10 PM

11 0

FRIDAY, Dec. 12, 2014 (HealthDay News) -- For women who have ductal carcinoma in situ surgically removed, a genetic test may help predict the odds of a recurrence, according to research presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 9 to 13 in San Antonio.

The Oncotype test analyzes certain cancer-linked genes to see how "active" they are, then gives the patient's sample a score between 0 and 100. The test had already been "validated" using tumor samples from patients enrolled in a clinical trial, Eileen Rakovitch, M.D., radiation oncologist at the Su...

Read more

To category page